CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,158 enrolled
Drug / intervention
fluorouracil +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00427310
NCT00427310Phase 3Completed

A Clinical Trial to Evaluate the Postoperative Portal Vein Infusion of 5-Fluorouracil and Heparin in Patients With Resectable Adenocarcinoma of the Colon

NSABP Foundation Inc·interventional·Posted Jan 29, 2007·Updated Jan 3, 2013

In Brief

A Phase 3 clinical trial evaluating fluorouracil, Observation, and 1 other intervention for Colorectal Cancer. Completed, enrolled 1,158 participants.

Detailed Summary

RATIONALE: Drugs used in chemotherapy, such as fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving fluorouracil into the liver is more effective than no further treatment for patients with colon cancer undergoing surgery. PURPOSE: This randomized phase III trial is studying giving infusions of fluorouracil into the liver in treating patients with Dukes' A, Dukes' B, or Dukes' C colon cancer undergoing surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

Phase 3CompletedFinished
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 29, 2007
Enrollment StartMar 1, 1984
Primary CompletionSep 1, 1989
Study CompletionFeb 1, 2001
TodayJul 1, 2026
Enrollment to primary: 5.5 yearsPosted 19.4 years ago

Interventions

fluorouracildrug

Observationother

sodium heparindrug